Endothelial progenitor cell dysfunction in cardiovascular diseases: role of reactive oxygen species and inflammation. 2013

Chih-Pei Lin, and Feng-Yen Lin, and Po-Hsun Huang, and Yuh-Lien Chen, and Wen-Chi Chen, and Huey-Yi Chen, and Yu-Chuen Huang, and Wen-Ling Liao, and Huey-Chun Huang, and Po-Len Liu, and Yung-Hsiang Chen
Department of Biotechnology and Laboratory Science in Medicine and Institute of Biotechnology in Medicine, National Yang-Ming University, Taipei 112, Taiwan.

Endothelial progenitor cells (EPCs) move towards injured endothelium or inflamed tissues and incorporate into foci of neovascularisation, thereby improving blood flow and tissue repair. Patients with cardiovascular diseases have been shown to exhibit reduced EPC number and function. It has become increasingly apparent that these changes may be effected in response to enhanced oxidative stress, possibly as a result of systemic and localised inflammatory responses. The interplay between inflammation and oxidative stress affects the initiation, progression, and complications of cardiovascular diseases. Recent studies suggest that inflammation and oxidative stress modulate EPC bioactivity. Clinical medications with anti-inflammatory and antioxidant properties, such as statins, thiazolidinediones, angiotensin II receptor 1 blockers, and angiotensin-converting enzyme inhibitors, are currently administered to patients with cardiovascular diseases. These medications appear to exert beneficial effects on EPC biology. This review focuses on EPC biology and explores the links between oxidative stress, inflammation, and development of cardiovascular diseases.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013234 Stem Cells Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells. Colony-Forming Units,Mother Cells,Progenitor Cells,Colony-Forming Unit,Cell, Mother,Cell, Progenitor,Cell, Stem,Cells, Mother,Cells, Progenitor,Cells, Stem,Colony Forming Unit,Colony Forming Units,Mother Cell,Progenitor Cell,Stem Cell
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen
D042783 Endothelial Cells Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer. Capillary Endothelial Cells,Lymphatic Endothelial Cells,Vascular Endothelial Cells,Capillary Endothelial Cell,Cell, Capillary Endothelial,Cell, Endothelial,Cell, Lymphatic Endothelial,Cell, Vascular Endothelial,Cells, Capillary Endothelial,Cells, Endothelial,Cells, Lymphatic Endothelial,Cells, Vascular Endothelial,Endothelial Cell,Endothelial Cell, Capillary,Endothelial Cell, Lymphatic,Endothelial Cell, Vascular,Endothelial Cells, Capillary,Endothelial Cells, Lymphatic,Endothelial Cells, Vascular,Lymphatic Endothelial Cell,Vascular Endothelial Cell
D018384 Oxidative Stress A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi). Anti-oxidative Stress,Antioxidative Stress,DNA Oxidative Damage,Nitro-Oxidative Stress,Oxidative Cleavage,Oxidative DNA Damage,Oxidative Damage,Oxidative Injury,Oxidative Nitrative Stress,Oxidative Stress Injury,Oxidative and Nitrosative Stress,Stress, Oxidative,Anti oxidative Stress,Anti-oxidative Stresses,Antioxidative Stresses,Cleavage, Oxidative,DNA Damage, Oxidative,DNA Oxidative Damages,Damage, DNA Oxidative,Damage, Oxidative,Damage, Oxidative DNA,Injury, Oxidative,Injury, Oxidative Stress,Nitrative Stress, Oxidative,Nitro Oxidative Stress,Nitro-Oxidative Stresses,Oxidative Cleavages,Oxidative DNA Damages,Oxidative Damage, DNA,Oxidative Damages,Oxidative Injuries,Oxidative Nitrative Stresses,Oxidative Stress Injuries,Oxidative Stresses,Stress Injury, Oxidative,Stress, Anti-oxidative,Stress, Antioxidative,Stress, Nitro-Oxidative,Stress, Oxidative Nitrative,Stresses, Nitro-Oxidative

Related Publications

Chih-Pei Lin, and Feng-Yen Lin, and Po-Hsun Huang, and Yuh-Lien Chen, and Wen-Chi Chen, and Huey-Yi Chen, and Yu-Chuen Huang, and Wen-Ling Liao, and Huey-Chun Huang, and Po-Len Liu, and Yung-Hsiang Chen
August 2011, Antioxidants & redox signaling,
Chih-Pei Lin, and Feng-Yen Lin, and Po-Hsun Huang, and Yuh-Lien Chen, and Wen-Chi Chen, and Huey-Yi Chen, and Yu-Chuen Huang, and Wen-Ling Liao, and Huey-Chun Huang, and Po-Len Liu, and Yung-Hsiang Chen
January 2018, Vascular pharmacology,
Chih-Pei Lin, and Feng-Yen Lin, and Po-Hsun Huang, and Yuh-Lien Chen, and Wen-Chi Chen, and Huey-Yi Chen, and Yu-Chuen Huang, and Wen-Ling Liao, and Huey-Chun Huang, and Po-Len Liu, and Yung-Hsiang Chen
January 2015, Oxidative medicine and cellular longevity,
Chih-Pei Lin, and Feng-Yen Lin, and Po-Hsun Huang, and Yuh-Lien Chen, and Wen-Chi Chen, and Huey-Yi Chen, and Yu-Chuen Huang, and Wen-Ling Liao, and Huey-Chun Huang, and Po-Len Liu, and Yung-Hsiang Chen
January 2005, Antioxidants & redox signaling,
Chih-Pei Lin, and Feng-Yen Lin, and Po-Hsun Huang, and Yuh-Lien Chen, and Wen-Chi Chen, and Huey-Yi Chen, and Yu-Chuen Huang, and Wen-Ling Liao, and Huey-Chun Huang, and Po-Len Liu, and Yung-Hsiang Chen
January 2012, International journal of inflammation,
Chih-Pei Lin, and Feng-Yen Lin, and Po-Hsun Huang, and Yuh-Lien Chen, and Wen-Chi Chen, and Huey-Yi Chen, and Yu-Chuen Huang, and Wen-Ling Liao, and Huey-Chun Huang, and Po-Len Liu, and Yung-Hsiang Chen
April 2011, Diabetes,
Chih-Pei Lin, and Feng-Yen Lin, and Po-Hsun Huang, and Yuh-Lien Chen, and Wen-Chi Chen, and Huey-Yi Chen, and Yu-Chuen Huang, and Wen-Ling Liao, and Huey-Chun Huang, and Po-Len Liu, and Yung-Hsiang Chen
March 2023, Molecular genetics and genomics : MGG,
Chih-Pei Lin, and Feng-Yen Lin, and Po-Hsun Huang, and Yuh-Lien Chen, and Wen-Chi Chen, and Huey-Yi Chen, and Yu-Chuen Huang, and Wen-Ling Liao, and Huey-Chun Huang, and Po-Len Liu, and Yung-Hsiang Chen
December 2010, World journal of cardiology,
Chih-Pei Lin, and Feng-Yen Lin, and Po-Hsun Huang, and Yuh-Lien Chen, and Wen-Chi Chen, and Huey-Yi Chen, and Yu-Chuen Huang, and Wen-Ling Liao, and Huey-Chun Huang, and Po-Len Liu, and Yung-Hsiang Chen
January 2012, Current pharmaceutical design,
Chih-Pei Lin, and Feng-Yen Lin, and Po-Hsun Huang, and Yuh-Lien Chen, and Wen-Chi Chen, and Huey-Yi Chen, and Yu-Chuen Huang, and Wen-Ling Liao, and Huey-Chun Huang, and Po-Len Liu, and Yung-Hsiang Chen
January 2013, International journal of inflammation,
Copied contents to your clipboard!